A top Food and Drug Administration official pledged Friday not to delay the rollout of coronavirus vaccines for the youngest children and said at least one of the two shots under review could become available as soon as June.

The FDA said it intends to convene meetings with its outside advisers on June 8, 21 and 22 to consider emergency use authorizations for coronavirus vaccines. Officials will decide closer to the meeting dates when the shots for young children will be considered, with that decision contingent on the status of the FDA reviews.

Moderna requested emergency use authorization for its vaccine for children 6 months to 5 years old on Thursday, and Pfizer and its German partner, BioNTech, are expected to submit the full data on a three-dose regimen for children 6 months to 4 years old in coming weeks. The companies have started submitting data to the agency.

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in an interview that the agency would not delay either vaccine to wait for the other. The vaccines’ applications, he said, would be considered as soon as they are ready.... Read More: Washington Post